Device
Nanodropper
Nanodropper is a medical device with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
1(20%)
Results Posted
100%(2 trials)
Terminated
1(20%)
Phase Distribution
Ph not_applicable
5
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Not yet recruiting1
Recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
66.7%
Most Advanced
N/A
Trials by Phase
N/A5 (100.0%)
Trials by Status
not_yet_recruiting120%
completed240%
recruiting120%
terminated120%
Recent Activity
1 active trials
Showing 5 of 5
not_yet_recruitingnot_applicable
Glaucoma Drop Aids Part 2
NCT06806332
terminatednot_applicable
Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma
NCT05273385
completednot_applicable
The Effect of Eyedrop Size on Pupillary Dilation Using the Nanodropper Bottle Adapter
NCT06689904
completednot_applicable
Efficacy of the Nanodropper Device on Pupillary Dilation
NCT05274321
recruitingnot_applicable
Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
NCT05844384
Clinical Trials (5)
Showing 5 of 5 trials
NCT06806332Not Applicable
Glaucoma Drop Aids Part 2
NCT05273385Not Applicable
Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma
NCT06689904Not Applicable
The Effect of Eyedrop Size on Pupillary Dilation Using the Nanodropper Bottle Adapter
NCT05274321Not Applicable
Efficacy of the Nanodropper Device on Pupillary Dilation
NCT05844384Not Applicable
Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5